These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11105535)

  • 61. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study.
    Chamilos G; Luna M; Lewis RE; Chemaly R; Raad II; Kontoyiannis DP
    Clin Ther; 2007 Sep; 29(9):1980-6. PubMed ID: 18035197
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients.
    Moreau P; Milpied N; Fayette N; Ramée JF; Harousseau JL
    J Antimicrob Chemother; 1992 Oct; 30(4):535-41. PubMed ID: 1490923
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial.
    Rijnders BJ; Cornelissen JJ; Slobbe L; Becker MJ; Doorduijn JK; Hop WC; Ruijgrok EJ; Löwenberg B; Vulto A; Lugtenburg PJ; de Marie S
    Clin Infect Dis; 2008 May; 46(9):1401-8. PubMed ID: 18419443
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy.
    Schuler U; Bammer S; Aulitzky WE; Binder C; Böhme A; Egerer G; Sandherr M; Schwerdtfeger R; Silling G; Wandt H; Glasmacher A; Ehninger G
    Onkologie; 2007 Apr; 30(4):185-91. PubMed ID: 17396041
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK.
    Bruynesteyn K; Gant V; McKenzie C; Pagliuca T; Poynton C; Kumar RN; Jansen JP
    Eur J Haematol; 2007 Jun; 78(6):532-9. PubMed ID: 17419744
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The lipid formulations of amphotericin B.
    Herbrecht R; Natarajan-Amé S; Nivoix Y; Letscher-Bru V
    Expert Opin Pharmacother; 2003 Aug; 4(8):1277-87. PubMed ID: 12877636
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Brief report: practicability and safety of amphotericin B deoxycholate as continuous infusion in neutropenic patients with hematological malignancies.
    Schulenburg A; Sperr W; Rabitsch W; Knöbl P; Thalhammer F
    Leuk Lymphoma; 2005 Aug; 46(8):1163-7. PubMed ID: 16085557
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.
    Boogaerts M; Winston DJ; Bow EJ; Garber G; Reboli AC; Schwarer AP; Novitzky N; Boehme A; Chwetzoff E; De Beule K;
    Ann Intern Med; 2001 Sep; 135(6):412-22. PubMed ID: 11560454
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.
    Maertens JA; Madero L; Reilly AF; Lehrnbecher T; Groll AH; Jafri HS; Green M; Nania JJ; Bourque MR; Wise BA; Strohmaier KM; Taylor AF; Kartsonis NA; Chow JW; Arndt CA; DePauw BE; Walsh TJ;
    Pediatr Infect Dis J; 2010 May; 29(5):415-20. PubMed ID: 20431381
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The use of liposomal amphotericin B in the treatment of neutropenia-associated fungal infections: efficacy and cost-effectiveness.
    Newland AC
    Br J Haematol; 1999 Feb; 104(2):425-6. PubMed ID: 10050732
    [No Abstract]   [Full Text] [Related]  

  • 72. Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients.
    Walsh TJ; Yeldandi V; McEvoy M; Gonzalez C; Chanock S; Freifeld A; Seibel NI; Whitcomb PO; Jarosinski P; Boswell G; Bekersky I; Alak A; Buell D; Barret J; Wilson W
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2391-8. PubMed ID: 9736569
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function.
    Botero Aguirre JP; Restrepo Hamid AM
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010481. PubMed ID: 26595825
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ten years' experience with liposomal amphotericin B in transplant recipients at Huddinge University Hospital.
    Ringdén O
    J Antimicrob Chemother; 2002 Feb; 49 Suppl 1():51-5. PubMed ID: 11801582
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Liposomal amphotericin B treatment for neonatal fungal infections.
    Scarcella A; Pasquariello MB; Giugliano B; Vendemmia M; de Lucia A
    Pediatr Infect Dis J; 1998 Feb; 17(2):146-8. PubMed ID: 9493812
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Fungal fatal attraction: a mechanistic review on targeting liposomal amphotericin B (AmBisome
    Soo Hoo L
    J Liposome Res; 2017 Sep; 27(3):180-185. PubMed ID: 28805117
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role of liposomal amphotericin B in the treatment of systemic fungal infections.
    Patterson TF; Andriole VT
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S63-8. PubMed ID: 2693111
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Amphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients.
    Johansen HK; Gotzsche PC
    Cochrane Database Syst Rev; 2000; (3):CD000239. PubMed ID: 10908468
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cost effectiveness of amphotericin B plus G-CSF compared with amphotericin B monotherapy. Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK.
    Flynn TN; Kelsey SM; Hazel DL; Guest JF
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):543-50. PubMed ID: 10662479
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B.
    Menichetti F; Del Favero A; Martino P; Bucaneve G; Micozzi A; D'Antonio D; Ricci P; Carotenuto M; Liso V; Nosari AM; Barbui T; Fasola G; Mandelli F;
    Ann Intern Med; 1994 Jun; 120(11):913-8. PubMed ID: 8172437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.